-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2020 to Q1 2024.
- Xeris Biopharma Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $7.03M, a 13.1% increase year-over-year.
- Xeris Biopharma Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $27.4M, a 63.3% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual Interest Expense for 2023 was $26.6M, a 88.7% increase from 2022.
- Xeris Biopharma Holdings, Inc. annual Interest Expense for 2022 was $14.1M, a 96.4% increase from 2021.
- Xeris Biopharma Holdings, Inc. annual Interest Expense for 2021 was $7.18M, a 32.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)